Statistics for Innate Pharma SA (id:10807 IPH)
Valuation metrics
Market cap
124.36M
Enterprise value
59.63M
Trailing P/E (ttm)
-15.73
Forward P/E
1.06
PEG ratio
0.18
Price/Sales (ttm)
3.68
Price/Book (mrq)
4.02
Enterprise Value/Revenue
1.76
Enterprise Value/EBITDA
-1.66
Overview
Shares outstanding
80.95M
Float
31.56M
Shares short
% Held by insiders
0.25%
% Held by institutions
0.10%
Average volume (10 days)
139.50K
Average volume (90 days)
Price summary
52-Week low
1.39
52-Week high
2.80
52-Week change
-68.08%
Beta
0.87
50-Day moving average
1.79
200-Day moving average
2.10
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
December 31th, 2023
Profitability
Profit margin
-100.78%
Operating margin
-213.15%
Operational effectiveness
Return on assets
-13.76%
Return on equity
-78.59%
Income statement
Revenue (ttm)
0.42
Revenue per share (ttm)
0.42
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-35,959,000.00
Net income to common (ttm)
-34,052,000.00
Diluted EPS (ttm)
-0.42
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
91.80M
Total cash per share (mrq)
1.13
Total debt (mrq)
35.50M
Total Debt/Equity (mrq)
123.29
Current ratio (mrq)
291.90%
Book value per share (mrq)
0.36
Cash flow
Cash flow statement
-18,057,000.00
Levered free cash flow (LFCF)
13.06M